These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5612197)

  • 1. [Treatment of patients with pulmonary tuberculosis with antibacterial preparations of the second series].
    Vasilik GV
    Vrach Delo; 1967 Apr; 4():48-51. PubMed ID: 5612197
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis].
    Iaschenko BP
    Probl Tuberk; 1967; 45(9):21-6. PubMed ID: 4303748
    [No Abstract]   [Full Text] [Related]  

  • 4. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV
    Probl Tuberk; 1968; 46(8):43-7. PubMed ID: 5709113
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of different combinations of antibacterial preparations on the activity of several enzymes in the tissues of guinea pigs with experimental tuberculosis].
    Izabolinskaia RM; Kruchakova FA; Polner RA
    Vopr Med Khim; 1973; 19(5):462-7. PubMed ID: 4363032
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA; Utkin VV; Korotaev GA; Golitsina LV
    Probl Tuberk; 1967; 45(5):29-33. PubMed ID: 5617941
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal function in patients with minor forms of pulmonary tuberculosis in the course of treatment with 2d series drugs].
    Stepanenko VA
    Vrach Delo; 1972 Aug; 8():97-8. PubMed ID: 5073195
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liver function in patients with pulmonary tuberculosis in the process of antibacterial therapy and after lung resection].
    Iglikov KT
    Vrach Delo; 1969 Mar; 3():73-6. PubMed ID: 5369662
    [No Abstract]   [Full Text] [Related]  

  • 9. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 10. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of age, sex and alcoholic habit of patients on liver enzymes during antituberculosis chemotherapy.
    Aggarwal NP; Kallan BM; Aggarwal M; Joshi R
    J Indian Med Assoc; 1991 Nov; 89(11):311-2. PubMed ID: 1787318
    [No Abstract]   [Full Text] [Related]  

  • 13. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)].
    Rizzo A; Magalhães M; Moura N
    Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP; Agarwala MC; Singh SK
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative results of the therapeutic action of morphazinamide and pyrazinamide combined with ethionamide in experimental tuberculosis in guinea pigs].
    Rözewska M
    G Ital Chemioter; 1967; 14(1):49-57. PubMed ID: 5622725
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of 2 or 3 secondary drug combinations in the retreatment of chronic pulmonary tuberculosis].
    De March Ayuela P; Turell Gumá J
    Rev Clin Esp; 1968 Apr; 109(2):117-26. PubMed ID: 4904020
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA; Korotaev GA; Poleshchuk AK; Utkin VV; Golitsyna LV
    Probl Tuberk; 1969; 47(1):27-33. PubMed ID: 5380204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kidney function in patients with pulmonary tuberculosis during treatment with antitubercular agents, with special reference to pyrazinamide].
    Spychalski W; Grzegorzewska A; Westfal I
    Pneumonol Pol; 1987 Oct; 55(10):454-7. PubMed ID: 3438179
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapeutic activity and diffusion properties of the second series antituberculous preparations].
    Drabkina RO; Ginzburg TS
    Klin Med (Mosk); 1966 Dec; 44(12):38-43. PubMed ID: 4302345
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of the treatment using pyrazinamide, ethioniamide and other drugs. Histoenzymological study on liver biopsies].
    Tarallo NH; Acosta-Ferreira W; Reissenweber NJ; Appeltauer LC; Sicardi R
    Hoja Tisiol; 1967; 24(1):104-22. PubMed ID: 4896550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.